SOLV vs TGT · P/E 9.1, rev $8.32B vs P/E 17, rev $51.98B
Solventum Corp. (SOLV) versus Target Corporation (TGT) — a side-by-side from cached financials, not a winner call.
Solventum Corp. (SOLV) is a medical instruments & supplies company listed on NYSE.
Target Corporation (TGT) is a discount stores company listed on NYSE. It is led by Brian Cornell.
Latest reported SOLV revenue for 2025-12-31 was $8.32B. Net income was $1.56B. Revenue was up 0.9% from 2024-12-31 to 2025-12-31. SOLV currently screens at market cap $12.91B and trailing P/E 9.1.
Latest reported TGT revenue for 2026-08-01 was $51.98B. Net income was $2.66B. TGT currently screens at market cap $58.05B and trailing P/E 16.9.
SOLV currently screens at market cap $12.91B and trailing P/E 9.1. TGT currently screens at market cap $58.05B and trailing P/E 16.9.
Not investment advice. Open the SOLV and TGT stock pages for the full models.
Not investment advice.